Results 161 to 170 of about 187,398 (301)
ABSTRACT We present the case of a 56‐year‐old male with non‐ST elevation myocardial infarction (NSTEMI) and a complex thrombotic lesion at the ostial left circumflex artery (LCX), extending into bifurcating marginal branches. Due to the high risk of side branch occlusion, a stentless strategy using thrombus aspiration, the reverse wire technique, and ...
Flavius‐Alexandru Gherasie +1 more
wiley +1 more source
ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li +4 more
wiley +1 more source
Editorial: Edema in heart failure with reduced ejection fraction
Inna P. Gladysheva +2 more
openaire +3 more sources
ABSTRACT Background Advanced heart failure (HF) remains a clinical challenge, and mitral transcatheter edge‐to‐edge repair (M‐TEER) has emerged as a potential bridging strategy. Aims To describe the clinical outcomes of M‐TEER in a single‐center cohort of patients with advanced HF and to identify anatomical and clinical features potentially associated ...
Pedro Castilhos de Freitas Crivelaro +8 more
wiley +1 more source
Predicting sudden cardiac death in heart failure with reduced ejection fraction. [PDF]
Mkrtchyan N +4 more
europepmc +1 more source
Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid +4 more
wiley +1 more source
Correction to: Hyperkalemia in heart failure with reduced ejection fraction: implications and management. [PDF]
Beavers CJ, Greene SJ.
europepmc +1 more source
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu +9 more
wiley +1 more source
Do obesity and visceral adiposity promote heart failure with reduced ejection fraction? [PDF]
Packer M.
europepmc +1 more source
ABSTRACT Background Chronic thromboembolic pulmonary disease (CTEPD) leads to chronic total occlusions (CTOs) of the pulmonary arteries in a minority of patients. Treatment of CTOs with balloon pulmonary angioplasty (BPA) may substantially improve patient hemodynamics but presents unique technical challenges and has previously been associated with a ...
Elliot J. Stein +4 more
wiley +1 more source

